Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus lidocaine with epinephrine for cleft palate repair
IRCT20210515051299N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-blind trial of ropivacaine, lidocaine and epinephrine in cleft palate (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Complications of anesthesia. Started Jun 2021; status: completed.
02
Drugs
ropivacainelidocaineepinephrine
03
Conditions
cleft palate
Beyond the preview
Go deeper on IRCT20210515051299N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210515051299N1.